Sequenom, Inc., a genetic analysis solutions provider, has sold its Bioscience business to Agena Bioscience, a portfolio company of Telegraph Hill Partners, for $31.8 million, subject to certain adjustments. Sequenom is also eligible to receive as much as $4 million for certain regulatory and sales milestones.   Agena Bioscience took on the facility lease for the Bioscience location in San Diego and will offer employment to all of the current Bioscience employees. The acquired business will cont...